Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-355-7 | CAS number: 139-13-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro:
Robbiano et al. (1999) studied an in vitro mammalian cell micronucleus test (method according to Bruggeman et al., 1989). Rat and human kidney cells were used, concentrations ranged from 1800 - 5600 umol, test done without metabolic activation. Trilon AS was positive for both cell types with slight toxicity at the highest dose.
Dunkel et al. (1985) showed a negative result testing Na3NTA.H2O in a bacterial reverse mutation assay. This test was done largely according to OECD guideline 471, concentrations ranged from 3 - 3333 ug/plate with and without metabolic activation.
Zeiger et al. (1992) also found a negative result testing Na3NTA.H2O in a bacterial reverse mutation assay. Concentrations ranged from 33 - 2000 ug/plate, tested with and without metabolic activation. This test was done also largely according to OECD guideline 471.
A cell transformation test with Trilon AS showed a positive result, when tested in concentrations up to > 10 mM with Syrian hamster embryo cells (LeBoeuf, 1996). Testing was done without metabolic activation.
Caspary et al. (1988) showed a negative result with Na3NTA.H2O in a mouse lymphoma assay using L5178Y cells with and without metabolic activation. Test concentrations were 1000 - 3000 ug/ml.
A sister chromatid exchange assay in mammalian cells was negative when tested without metabolic activation with CHO cells. Concentrations used were 0.001 - 2 mM of Trilon A (Montaldi et al., 1985).
Celotti et al. (1987) tested V79 Chinese hamster cells with and without metabolic activation in a mammalian cell gene mutation assay. Negative results were obtained using Na3NTA in concentrations of 0.1 - 15 mM.
Montaldi (1985) reported a negative result for Trilon A in a sister chromatid exchange assay in mammalian cells, Nakatsuka (1990) found a positive result in a mammalian cell gene mutation assay with Fe+-NTA and a negative result with Fe+NTA in a mammalian chromosome aberration test, Lanfranchi reported a negative result for Na3NTA in a cell transformation assay, Traul (1981) showed a positive result in a cell transformation assay wtih Trilon A, Miltenburger (1995) reported a positive result in a mammalian abberation test with Trilon A and DeMarco (1986) found a positive result in a mammalian chromosome aberration assay with Trilon A.
In vivo:
With Trilon AS, inconclusive results were reported when tested oral and i.v. in a micronucleus assay (Robbiano, 1999). Male rats were given the test substance i.v. in a concentration of 250 mg/kg and a single p.o. administration of 1/2 of the LD50 performed 2 days after folic acid injection or as three p.o. administrations of 1/3 of the LD50 during the 3 days after folic acid injection. In both cases, rats were euthanized 4 days after folic acid treatment.
A micronucleus test according to OECD guideline 474 with Trilon A reported negative results when using doses of 500, 1000 and 2000 mg/kg. The test substance was given twice orally (gavage), male mice were used for this test (BASF, 2004).
A mammalian germ cell cytogenetic assay was done with Trilon A using male mice (BASF, 2000). The test substance was given orally (gavage) in doses of 100, 330 and 1000 mg/kg. Negative results were found.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Classification:
Most of the above mentioned studies showed negative results (in vitro as well as in vivo). Classification regarding mutagenicity is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.